CVS Health Corporation $CVS Shares Sold by National Pension Service

National Pension Service cut its holdings in CVS Health Corporation (NYSE:CVS) by 0.5% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 3,404,216 shares of the pharmacy operator’s stock after selling 15,397 shares during the quarter. National Pension Service’s holdings in CVS Health were worth $352,166,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 281 shares during the last quarter. Swiss RE Ltd. acquired a new position in shares of CVS Health during the 4th quarter worth approximately $26,000. Kilter Group LLC purchased a new stake in CVS Health in the 2nd quarter valued at approximately $27,000. Sankala Group LLC acquired a new stake in CVS Health during the 4th quarter valued at $28,000. Finally, Global Trust Asset Management LLC increased its position in CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 300 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Down 0.7%

CVS opened at $95.43 on Thursday. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The business has a 50-day moving average of $100.31 and a two-hundred day moving average of $90.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The stock has a market capitalization of $122.05 billion, a price-to-earnings ratio of 25.25, a price-to-earnings-growth ratio of 0.94 and a beta of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period in the prior year, the firm posted $1.81 EPS. The company’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is 70.37%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Cantor Fitzgerald upped their price objective on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Wells Fargo & Company lifted their price objective on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Morgan Stanley upped their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. UBS Group decreased their price target on shares of CVS Health from $126.00 to $118.00 and set a “buy” rating on the stock in a research note on Thursday, September 3rd. Finally, JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Twenty-two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $107.24.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Recent coverage highlighted CVS Health’s improving business performance and financial results. The company’s latest reported quarter included adjusted earnings of $2.58 per share, above the $1.87 analyst consensus, while revenue increased 7.3% year over year. CVS has issued fiscal 2026 earnings guidance of $7.90–$8.10 per share. Wall Street Loves CVS Health Stock Right Now. Should You?
• Positive Sentiment: Zacks identified CVS as a strong momentum stock, while increased investor attention could support near-term trading interest. These assessments are based largely on quantitative and sentiment factors rather than a new company announcement. Here’s Why CVS Health Is a Strong Momentum Stock
• Neutral Sentiment: CVS marked the 20th anniversary of its free community health-screening program. A company-commissioned survey found that nearly one in four U.S. adults has delayed contacting a health professional because of access, cost or availability barriers, while one-third were unaware of community screening programs. The initiative may support CVS’s community-health reputation but is unlikely to materially affect near-term earnings. CVS Health Community Health Screening Program
• Negative Sentiment: CVS flagged elevated medical expenses, raising concerns about profit margins and earnings visibility across its managed-care operations. The warning pressured the broader managed-care group and is the clearest near-term reason for weakness in CVS stock. CVS Health Flags Elevated Medical Expenses

About CVS Health

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.